Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.700
+0.080 (1.73%)
Jul 9, 2026, 2:36 PM EDT - Market open
Minerva Neurosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
218.97M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 151.12M |
| Cellectis | 75.11M |
| Compugen | 72.66M |
| Arcturus Therapeutics Holdings | 54.71M |
| Atrium Therapeutics | 36.68M |
| Voyager Therapeutics | 36.49M |
| Keros Therapeutics | 33.18M |
| Alector | 18.42M |
NERV News
- 4 weeks ago - Minerva Neurosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Minerva Neurosciences Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs - GlobeNewsWire
- 7 weeks ago - Minerva Neurosciences Slides: Corporate presentation - Filings
- 7 weeks ago - Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Minerva Neurosciences Provides First Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Minerva Neurosciences Earnings release: Q1 2026 - Filings
- 2 months ago - Minerva Neurosciences Quarterly report: Q1 2026 - Filings